BioPlus Acquisition Corp.

BioPlus Acquisition Corp. (ticker: BIOS) is a blank check company formed to identify and complete a business combination within the healthcare and life sciences sector. The SPAC completed its initial public offering in 2021 and filed its annual report on Form 10-K with the SEC on March 31, 2023, covering the fiscal year ended December 31, 2022, under accession number 0001193125-23-087738. As of that filing date, the company remained in its search phase, evaluating potential acquisition targets across the biopharmaceutical and broader life sciences industries. Investors and analysts tracking BIOS and the wider SPAC market can sign up at SpacDesk for full filing data, deal timelines, and real-time analytics.